Shionogi Europe, a leading global research-driven pharmaceutical company is seeking late-stage, hospital‑focused assets and platforms for the treatment of paediatric diseases. Therapeutics for a wide range of paediatric conditions for use in a hospital setting, other than those listed as out of scope below, are of interest.
Approaches of Interest:
- Therapeutics addressing unmet needs in rare or infectious diseases and critical care are of the highest priority, but others will also be considered.
- Small molecule and peptide modalities are preferred.
- All delivery...